Phenylalanine
  Uses of this Supplement
Depression
Multiple Sclerosis
Osteoarthritis
Parkinson's Disease
Rheumatoid Arthritis
  Supplements with Similar Uses
View List by Use
  Drugs that Interact
Summary
Baclofen
Levodopa
Levodopa-containing Medications
  Supplements with Similar Side Effects
View List by Side Effect
  Supplements with Similar Warnings
View List by Warning
  Learn More About
Nutrition
Look Up > Supplements > Phenylalanine > Interactions
Interactions with Phenylalanine
Baclofen

In situ, phenylalanine (up to 100 mM) decreased the absorption of isotonic perfusion solutions of baclofen (0.5 mM) in the rat small intestine by 67% (Cejudo-Ferragud et al. 1996). To maximize absorption of the drug, baclofen should not be administered with meals, especially meals high in protein content.

18F-DOPA

Infusion of L-phenylalanine prior to administration of 3-O-methyl-6-[18F]fluoro-L-DOPA (18F-DOPA) prevented 18F-DOPA uptake in the brain (Doudet et al. 1992). L-phenylalanine improved specific-to-non-specific contrast images of 18F-DOPA during positron emission tomography (PET) scanning.

Levodopa

Administration of levodopa (1 mg/kg/hour IV) following administration of phenylalanine (100 or 200 mg/kg po) in two patients with advanced Parkinson's disease altered the clinical effects of the drug (Woodward, et al. 1998). The therapeutic response to levodopa could be diminished when administered at the same time as phenylalanine.


References

Cejudo-Ferragud E, Nacher A, Polache A, Cercos-Fortea T, Merino M, Casabo VG. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine, Int J of Pharm (Amsterdam). 1996;132:63-69.

Doudet D, McLellan CA, Aigner TG, Wyatt RJ, Cohen RM. Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-non-specific fluorine-18-DOPA uptake in brain. J of Nucl Med. 1992;33(7):1383-1389.

Woodward, WR, Olanow CW, Beckner Rm et al. The effect of L-dopa infusions with and without phenylalanine challenges in parkinsonian patients. Neurol. 1998;48:1704-1708.


Copyright © 2000 Integrative Medicine Communications

This publication contains information relating to general principles of medical care that should not in any event be construed as specific instructions for individual patients. The publisher does not accept any responsibility for the accuracy of the information or the consequences arising from the application, use, or misuse of any of the information contained herein, including any injury and/or damage to any person or property as a matter of product liability, negligence, or otherwise. No warranty, expressed or implied, is made in regard to the contents of this material. No claims or endorsements are made for any drugs or compounds currently marketed or in investigative use. The reader is advised to check product information (including package inserts) for changes and new information regarding dosage, precautions, warnings, interactions, and contraindications before administering any drug, herb, or supplement discussed herein.